Annals of the Rheumatic Diseases, ‎0003-4967

Journal

Publications

  1. Published
  2. E-pub ahead of print

    2016 update of the EULAR recommendations for the management of early arthritis

    Karim Raza, 15 Dec 2016, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  3. Published
  4. Published

    2019 update of the EULAR recommendations for the management of systemic lupus erythematosus

    Caroline Gordon, 29 Mar 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 736-745 10 p.

    Research output: Contribution to journalReview articlepeer-review

  5. Published
  6. Published
  7. Published

    A pilot study to compare computerised DMARD monitoring with manual monitoring

    1 Jan 2004, In: Annals of the Rheumatic Diseases. 63, p. 558 1 p.

    Research output: Contribution to journalAbstract

  8. Published
  9. Published
  10. Published
  11. Published
  12. Published
  13. Published
  14. Published
  15. Published

    Anti-collagen type II antibodies in patients with very early synovitis

    Karim Raza, , Mike Salmon, Christopher Buckley & , 1 Sep 2008, In: Annals of the Rheumatic Diseases. 67, 9, p. 1354-1355 2 p.

    Research output: Contribution to journalLetter

  16. Published

    Anti-modified citrullinated vimentin (MCV) antibodies in patients with very early synovitis

    Karim Raza, , Christopher Buckley, Andrew Filer & , 20 Oct 2009, In: Annals of the Rheumatic Diseases. 69, 3, p. 627-628 2 p.

    Research output: Contribution to journalArticlepeer-review

  17. E-pub ahead of print

    Antibodies against collagen type II are not a general marker of acute arthritis onset

    Andrew Filer, Karim Raza & , 24 Aug 2017, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalLetterpeer-review

  18. Published

    Antibodies to citrullinated α-enolase peptide 1 and clinical and radiological outcomes in rheumatoid arthritis

    Benjamin Fisher, , , , , , , & , 2011, In: Annals of the Rheumatic Diseases. 70, 6, p. 1095-8 4 p.

    Research output: Contribution to journalArticlepeer-review

  19. Published

    Antibodies to protein P in systemic lupus erythematosus

    Caroline Gordon, Paul Emery, , , & , Apr 1992, In: Annals of the Rheumatic Diseases. 51, 4, p. 489-94 6 p.

    Research output: Contribution to journalArticlepeer-review

  20. Published

    Are there specific genetic risk factors for the different forms of ANCA-associated vasculitis?

    Lorraine Harper, , , & , 1 Apr 2011, In: Annals of the Rheumatic Diseases. 70, 4, p. 707-U197

    Research output: Contribution to journalArticle

  21. Published

    Assessment of lupus: where are we now?

    Caroline Gordon & Paul Emery, Mar 1993, In: Annals of the Rheumatic Diseases. 52, 3, p. 169-72 4 p.

    Research output: Contribution to journalArticlepeer-review

  22. Published
  23. Published
  24. Published
  25. Published
  26. Published

    BILAG-2004 index captures systemic lupus erythematosus disease activity better than SLEDAI-2000

    Chee Yee, , , , , , , , , , , , , & Caroline Gordon, 1 Jun 2008, In: Annals of the Rheumatic Diseases. 67, 6, p. 873-6 4 p.

    Research output: Contribution to journalArticle

  27. Published

    Bridging the gap in rheumatology

    Janet McDonagh, Taunton Southwood & , 1 Jan 2000, In: Annals of the Rheumatic Diseases. 59, p. 575-584 10 p.

    Research output: Contribution to journalArticle

  28. Published
  29. Published
  30. Published

    Clinical associations of the metabolic syndrome in systemic lupus erythematosus: data from an international inception cohort

    Caroline Gordon & 19 others, , , , , , , , , , , , , , , , , , & , Aug 2013, In: Annals of the Rheumatic Diseases. 72, 8, p. 1308-14 7 p.

    Research output: Contribution to journalArticlepeer-review

  31. Published
  32. Published

    Current challenges in the development of new treatments for lupus

    Caroline Gordon, , & , 12 Jan 2019, In: Annals of the Rheumatic Diseases. 78, 6, p. 729-735 7 p.

    Research output: Contribution to journalArticlepeer-review

  33. Published

    Cutaneous abnormalities in rheumatoid arthritis compared to non-inflammatory rhuematic conditions

    Gareth Treharne, , Nicola Erb & , 28 Mar 2006, In: Annals of the Rheumatic Diseases. 65, 10, p. 1341-1345 5 p.

    Research output: Contribution to journalArticle

  34. Published
  35. Published

    Damage in the anca-associated vasculitides: long-term data from the European vasculitis study group (EUVAS) therapeutic trials

    Lorraine Harper, , , , & , Jan 2015, In: Annals of the Rheumatic Diseases. 74, 1, p. 177-84 8 p.

    Research output: Contribution to journalArticlepeer-review

  36. Published
  37. Published
  38. Published
  39. Published
  40. Published
  41. Published

    Development of comprehensive disease assessment in systemic vasculitis

    Paul Bacon, , , , , & , 1 Mar 2007, In: Annals of the Rheumatic Diseases. 66, 3, p. 283-92 10 p.

    Research output: Contribution to journalArticle

  42. Published
  43. Accepted/In press
  44. Published
  45. Published
  46. Published
  47. Published

    EULAR definition of arthralgia suspicious for progression to rheumatoid arthritis

    Karim Raza, 1 Mar 2017, In: Annals of the Rheumatic Diseases. 76, 3, p. 491-496 6 p.

    Research output: Contribution to journalArticlepeer-review

  48. E-pub ahead of print

    EULAR points to consider for conducting clinical trials and observational studies in individuals at risk of rheumatoid arthritis

    Karim Raza, , , , & , 6 Aug 2021, (E-pub ahead of print) In: Annals of the Rheumatic Diseases.

    Research output: Contribution to journalArticlepeer-review

  49. Published
  50. Published
Previous 1 2 3 4 Next